Risk-Based Monitoring With Closed-Loop CAPA
Risk-based, live, protocol-aware oversight that surfaces risk as it emerges, tied to its timeline impact, with the right action attached.
“When did you know the trial was off track, and why are we only hearing about it now?”
Monitors fly blind until they are on site. Signals sit in separate systems, detection takes days, and there is no closed loop from a breach to a verified fix.
Risk-based, quality-by-design oversight
The first GCP overhaul in three decades — explicitly embracing modern technology, data governance, and risk-based monitoring across the trial.
Breach → CAPA → verified closure
Every insight references the exact TMP / SMP section, and each breach moves to CAPA and verified closure automatically.
Innovo Copilot
How Innovo Copilot Handles Monitoring And CAPA
Real-time closed loop risk-based monitoring
One live site-risk score across EDC / CTMS / eTMF
Breach → CAPA → verified closure, automatically
Role-based dashboards grounded in the plan
Pre-visit briefing → monitoring visit report → closeout
The Outcomes Clinical Teams Care About
-
~80%
Faster breach-to-CAPA
-
30–50%
Expanded CRA capacity
-
3–5h
Saved per CRA visit
Frequently Asked Questions
Plain answers on risk-based monitoring and capa.
-
By closing the loop in one system. Innovo Copilot keeps one live site-risk score across EDC, CTMS and eTMF and moves each breach to CAPA and verified closure automatically: about 80% faster breach-to-CAPA.
-
By taking preparation and write-up off the CRA. Pre-visit briefings and monitoring visit reports are drafted for review, with about 70% of the report pre-filled, saving 3–5 hours per visit and expanding CRA capacity by 30–50%.
-
Innovo Copilot drafts the monitoring visit report from the pre-visit briefing through closeout, and every insight references the exact TMP / SMP section it relates to.
-
EDC, CTMS and eTMF. InnovoClinical features a RESTful API and pre-built connectors for major industry platforms.
Part Of Innovo Copilot
Monitoring is the third step of a closed loop: Plan → Author → Monitor. Every phase feeds the next. More solutions: Protocol Authoring · Amendments & Deviations · Sponsor Oversight & ICH E6(R3) · Study Startup.
Ready To Accelerate Clinical Trial Execution?
Connect with our team today to see how the Innovo platform can transform your operational efficiency.